Published in Healthcare Mergers, Acquisitions and Ventures Week, December 23rd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Sangamo BioSciences.
Report 1: Sangamo BioSciences, Inc. (SGMO) announced the presentation of preclinical data from its ZFP Therapeutic program in nerve regeneration at the 2006 Annual Meeting of The Society for Neuroscience held in Atlanta, Georgia.
Michael Fehlings, MD, PhD, Sangamo's collaborator, gave the presentation, titled "Examination of The Therapeutic Effect of An Engineered Transcription Factor Promoting Activation of Vascular Endothelial Growth Factor in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.